compounding semaglutide fda enforcement news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The FDA's Decision to Ban

In one study, people without diabetes who took semaglutide (the active ingredient in Ozempic and Wegovy) were slightly more likely to be diagnosed with ED than those taking a placebo

Both medications reduce hunger, improve satiety, and promote sustainable fat loss when paired with healthy eating and physical activity

The sign-in flow should reduce friction, while still preserving essential safeguards

Blanck P, Stoffel M, Bents H, et al

For life-threatening symptoms such as chest pain, severe allergic reaction, or loss of consciousness, call 999 immediately

Since May 2018, she has been contributing to Medical Dialogues, writing and editing medical news articles that translate complex research into clear, accessible information for healthcare professionals